Discover 1,039 paid clinical trials in West Palm Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,039
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing
for
Diabetic Foot Ulcers (DFUs),
Location: Tamarac FL
Sponsor: Reprise Biomedical, Inc.
Sex: All
Age: 18+
Code: NCT06939686
Recruiting
Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
for
Diabetic Foot Ulcers (DFUs), Venous Leg Ulcers (VLUs),
Location: Tamarac FL
Sponsor: Reprise Biomedical, Inc.
Sex: All
Age: 18+
Code: NCT06939673
Recruiting
Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers
for
Peripheral Artery Disease,
Location: Tamarac FL, Deerfield Beach FL, South Miami FL,
Sponsor: AnGes USA, Inc.
Sex: All
Age: 18+
Code: NCT04267640
Phase2, Recruiting
AngelMed Guardian® System PMA Post Approval Study
for
Acute Coronary Syndrome
Location: Fort Lauderdale FL, Miami FL, Clermont FL,
Sponsor: Angel Medical Systems
Sex: All
Age: 21+
Code: NCT05412927
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Tamarac FL, Plantation FL, Port Saint Lucie FL,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase3, Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Fort Lauderdale FL, Jacksonville FL, Richmond VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase2, Phase3, Recruiting
OLE Therapy With BE Patients in Home Care Study
for
Bronchiectasis, Pulmonary Exacerbation
Location: Tamarac FL, Port Saint Lucie FL, Orlando FL, Tampa FL,
Sponsor: Delve Health
Sex: All
Age: 5+
Code: NCT06926881
Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for
Rhinovirus Infection
Location: Tamarac FL, Miami Lakes FL, Bradenton FL, East Point GA,
Sponsor: Altesa Biosciences, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07610395
Phase2, Recruiting
Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
for
First Episode Psychosis
Location: Lauderdale Lakes FL
Sponsor: Northwell Health
Sex: All
Age: 15 - 40
Code: NCT04004364
Recruiting
A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics
for
Glaucoma, Suspect,
Location: Fort Lauderdale FL
Sponsor: Nova Southeastern University
Sex: All
Age: 5 - 8
Code: NCT02157025
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Lauderhill FL, Cooper City FL, Miami FL, Naples FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 55
Code: NCT07410507
Phase2, Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
for
Glomerular Disease, Proteinuria
Location: Lauderdale Lakes FL, Tampa FL, Columbus GA,
Sponsor: Angion Biomedica Corp
Sex: All
Age: 18+
Code: NCT04939116
Phase2, Recruiting
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment